Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis with delayed-release 6-mercaptopurine

Treatment of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis with delayed-release 6-mercaptopurine

US Patent 10828308 · Granted Nov 10, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Low dose pridopidine for Parkinson's Disease and other diseases associated with 2025
Use of pridopidine for treating rett syndrome2024
Pridopidine for treating drug induced dyskinesias2024
Identifying and quantifying individualized variability-patterns and implementing2024
Use of pridopidine for treating dystonias2023
Subject-specific system and method for prevention of body adaptation for chronic2023
Methods and systems for modulating physiological states between biological entit2023
Use of pridopidine to improve cognitive function and for treating Alzheimer's di2022
Method of treating amyotrophic lateral sclerosis with pridopidine2022
Use of pridopidine for the treatment of fragile X syndrome2022
Use of pridopidine for treating functional decline2021
Devices and methods for detection of internal bleeding and hematoma2021